中国中西医结合肾病杂志
中國中西醫結閤腎病雜誌
중국중서의결합신병잡지
CHINESE JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN NEPHROLOGY
2014年
8期
669-671
,共3页
刘明%张晓东%方敬爱%孙艳艳%刘文媛
劉明%張曉東%方敬愛%孫豔豔%劉文媛
류명%장효동%방경애%손염염%류문원
氯沙坦钾%糖尿病肾病%p-JAK2%p-STAT3%VEGF
氯沙坦鉀%糖尿病腎病%p-JAK2%p-STAT3%VEGF
록사탄갑%당뇨병신병%p-JAK2%p-STAT3%VEGF
Losartan potassium%Diabetic nephropathy%p - JAK2%p - STAT3%VEGF
目的:探讨氯沙坦钾对糖尿病肾病(diabetic nephropathy,DN)大鼠肾组织 p - JAK2、p - STAT3及 VEGF 表达的影响。方法:健康雄性 SD 大鼠30只随机分为正常对照组(C 组)、DN 模型组(DN 组)、氯沙坦钾组(L 组)。采用单次腹腔内注射链脲佐菌素(streptozotocin,STZ)法建立 DN 大鼠模型,周期12周。实验12周末检测大鼠血糖、Scr、BUN、24 h 尿蛋白定量;光镜及电镜下观察大鼠肾组织病理改变;采用免疫组化方法检测大鼠肾组织 p - JAK2、p - STAT3、VEGF 表达。结果:实验12周末,模型组大鼠血糖、Scr、BUN、24 h 尿蛋白定量均高于对照组(P ﹤0.05),肾组织中 p - JAK2、p - STAT3、VEGF 表达均高于对照组(P ﹤0.05);氯沙坦钾组大鼠 Scr、BUN、24 h 尿蛋白定量均低于模型组(P ﹤0.05),肾组织 p - JAK2、p -STAT3、VEGF 表达均低于模型组(P ﹤0.05)。结论:氯沙坦钾可能部分通过调控 p - JAK2、p - STAT3及 VEGF 的表达而发挥肾脏保护作用。
目的:探討氯沙坦鉀對糖尿病腎病(diabetic nephropathy,DN)大鼠腎組織 p - JAK2、p - STAT3及 VEGF 錶達的影響。方法:健康雄性 SD 大鼠30隻隨機分為正常對照組(C 組)、DN 模型組(DN 組)、氯沙坦鉀組(L 組)。採用單次腹腔內註射鏈脲佐菌素(streptozotocin,STZ)法建立 DN 大鼠模型,週期12週。實驗12週末檢測大鼠血糖、Scr、BUN、24 h 尿蛋白定量;光鏡及電鏡下觀察大鼠腎組織病理改變;採用免疫組化方法檢測大鼠腎組織 p - JAK2、p - STAT3、VEGF 錶達。結果:實驗12週末,模型組大鼠血糖、Scr、BUN、24 h 尿蛋白定量均高于對照組(P ﹤0.05),腎組織中 p - JAK2、p - STAT3、VEGF 錶達均高于對照組(P ﹤0.05);氯沙坦鉀組大鼠 Scr、BUN、24 h 尿蛋白定量均低于模型組(P ﹤0.05),腎組織 p - JAK2、p -STAT3、VEGF 錶達均低于模型組(P ﹤0.05)。結論:氯沙坦鉀可能部分通過調控 p - JAK2、p - STAT3及 VEGF 的錶達而髮揮腎髒保護作用。
목적:탐토록사탄갑대당뇨병신병(diabetic nephropathy,DN)대서신조직 p - JAK2、p - STAT3급 VEGF 표체적영향。방법:건강웅성 SD 대서30지수궤분위정상대조조(C 조)、DN 모형조(DN 조)、록사탄갑조(L 조)。채용단차복강내주사련뇨좌균소(streptozotocin,STZ)법건립 DN 대서모형,주기12주。실험12주말검측대서혈당、Scr、BUN、24 h 뇨단백정량;광경급전경하관찰대서신조직병리개변;채용면역조화방법검측대서신조직 p - JAK2、p - STAT3、VEGF 표체。결과:실험12주말,모형조대서혈당、Scr、BUN、24 h 뇨단백정량균고우대조조(P ﹤0.05),신조직중 p - JAK2、p - STAT3、VEGF 표체균고우대조조(P ﹤0.05);록사탄갑조대서 Scr、BUN、24 h 뇨단백정량균저우모형조(P ﹤0.05),신조직 p - JAK2、p -STAT3、VEGF 표체균저우모형조(P ﹤0.05)。결론:록사탄갑가능부분통과조공 p - JAK2、p - STAT3급 VEGF 적표체이발휘신장보호작용。
Objective:To investigate the effect of Losartan Potassium on p - JAK2,p - STAT3 and VEGF of renal tissue in the diabetic nephropathy rats. Methods:30 SD male rats were divided randomly into control group(group C),diabetic nephropathy group(group DN),Losartan Potassium group(group L). The rats were being intraperitoneal injected with STZ(1% ,45 mg/ kg)to establish diabetic nephropathy rats models,test period 12 weeks. Blood glucose,Scr,BUN,24 - hour urinary protein were measured at the 12th. The renal pathological changes were detected by light microscope and electron microscopy. The expression of p - JAK2, p - STAT3 and VEGF were detected by immunohistochemistry staining sections. Results:After establishing mode for 12 weeks,com-pared with group C,group DN had significant elevated blood glucose,24 - hour urinary protein,Scr,BUN(P ﹤ 0. 05),and immuno-histochemistry staining displayed that the expression of p - JAK2,p - STAT3,VEGF remarkably increased(P ﹤ 0. 05). Compared with group DN,group L had significantly lower 24 urinary protein,Scr,BUN(P ﹤ 0. 05),the expression of p - JAK2,p - STAT3, VEGF were lower than those in group DN(P ﹤ 0. 05). Conclusion:Losartan Potassium may in part through regulating the expression of p - JAK2,p - STAT3 and VEGF play a protective role in the kidney of diabetic nephropathy rats.